Korkmaz, S. Et Al. 2019. Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1 , 265-271.

Korkmaz, S., Erdem, S., Akay, E., Tasdemir, E. A., Karaman, H., & Keklik, M., (2019). Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, 265-271.

Korkmaz, Serdal Et Al. "Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, 265-271, 2019

Korkmaz, Serdal Et Al. "Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.265-271, 2019

Korkmaz, S. Et Al. (2019) . "Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.265-271.

@article{article, author={Serdal Korkmaz Et Al. }, title={Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2019, pages={265-271} }